It corresponds to the existing literature, which exposes the increasing sensitivity of this population to TB, especially when one goes through immune stress therapy such as corticosteroids, tumor necrosis factor-alpha (TNF-α) inhibitors, etc.  Conclusion: LTBI represents a silent threat to TB control. This evidence concerns the gene TNF and tuberculosis.